Sozzani P, Hasan L, Séguélas M H, Caput D, Ferrara P, Pipy B, Cambon C
Laboratoire de l'Université P. Sabatier, CHU Rangueil, Toulouse, France.
Biochem Biophys Res Commun. 1998 Mar 27;244(3):665-70. doi: 10.1006/bbrc.1998.8314.
Here we analysed the involvement of tyrosine phosphorylation in the regulation of the initial molecular events induced by IL-13 to modulate TPA-triggered reactive oxygen intermediates (ROI) production. Our data indicate that treatment of monocytes with a protein tyrosine kinase inhibitor (herbimycin A) prevents IL-13-induced cAMP accumulation and subsequent ROI inhibition. We have previously demonstrated that cAMP accumulation depends on inositol phosphates hydrolysis (InsPs) and intracellular Ca2+ mobilisation. The inhibition of InsPs and intracellular Ca2+ release by herbimycin A suggests a primary role of tyrosine kinases upstream PLC activation. We further specify that IL-13 stimulates PLC-gamma 1 and IRS-2 tyrosine phosphorylation in human monocytes. We demonstrate for the first time that IL-13 induces the association of IRS-2 with PLC-gamma 1. We proposed here that PLC-gamma 1 is a new candidate recruited by IRS-2.
在此,我们分析了酪氨酸磷酸化在白细胞介素-13(IL-13)诱导的初始分子事件调控中的作用,这些事件可调节佛波酯(TPA)触发的活性氧中间体(ROI)生成。我们的数据表明,用蛋白酪氨酸激酶抑制剂(赫曲霉素A)处理单核细胞可阻止IL-13诱导的环磷酸腺苷(cAMP)积累及随后的ROI抑制。我们之前已证明,cAMP积累依赖于肌醇磷酸水解(InsPs)和细胞内钙离子动员。赫曲霉素A对InsPs和细胞内钙离子释放的抑制表明酪氨酸激酶在磷脂酶C(PLC)激活上游起主要作用。我们进一步明确,IL-13可刺激人单核细胞中PLC-γ1和胰岛素受体底物-2(IRS-2)的酪氨酸磷酸化。我们首次证明,IL-13可诱导IRS-2与PLC-γ1结合。我们在此提出,PLC-γ1是由IRS-2招募的新候选分子。